Please provide your email address to receive an email when new articles are posted on . FibroTest showed low accuracy in detecting significant fibrosis and cirrhosis among patients with chronic ...

Researchers found transient elastography and FibroTest to be effective, noninvasive tools for hepatoxicity monitoring in patients with psoriasis who are treated with methotrexate. The researchers ...

In recent years the use of non-invasive biomarkers to assess liver fibrosis has become widely accepted. Although the combination of surrogate markers, such as those employed by the FibroTest, have a ...

Background: FibroTest (FT) is a biomarker of liver fibrosis initially validated in patients with chronic hepatitis C (CHC). The aim was to test two hypotheses, one, that the FT diagnostic value was ...

Noninvasive tests for liver fibrosis, such as liver stiffness measurement or the FibroTest, can predict survival of patients with chronic hepatitis C. Non-invasive tests for liver fibrosis, such as ...

Seventy-four patients were included in the analysis: 36 patients with HCV infection, 10 with HBV infection, and 28 with PBC. Patients' characteristics are shown in table 1. The Spearman correlation ...

Disease etiology is a major factor in the performance of noninvasive fibrosis biomarkers, according to new research published in Alimentary Pharmacology & Therapeutics. Moreover, the findings from ...

Non-invasive tests for liver fibrosis, such as liver stiffness measurement or the FibroTest, can predict survival of patients with chronic hepatitis C, according to a new study in Gastroenterology, ...